Feline Infectious Peritonitis: Comprehensive Guide For 2025

Feline Infectious Peritonitis (FIP) stands as one of the most challenging and historically lethal diseases affecting domestic cats. Triggered by a mutation in the common feline coronavirus, this condition leads to widespread inflammation and organ damage. While once considered invariably fatal, recent advancements in antiviral therapies have transformed prognosis for many affected cats. This article delves into the nature of FIP, its clinical presentations, diagnostic approaches, treatment options, and preventive strategies, equipping cat owners and veterinary professionals with vital knowledge.

The Viral Origins of FIP

At its core, FIP arises from feline coronavirus (FCoV), a ubiquitous virus shed primarily through feces in multi-cat environments. Most FCoV infections remain benign, causing only mild intestinal upset akin to feline enteric coronavirus (FECV). However, in a small percentage of cases—estimated at 5-10%—the virus undergoes a critical mutation, evolving into FIP virus (FIPV). This shift enables replication within macrophages, white blood cells that carry the virus systemically, sparking an aberrant immune response.

Factors influencing mutation include viral strain virulence, host genetics, age, and environmental stress. Young cats under one year, purebreds, and those in catteries or shelters face heightened risk due to intense viral exposure and immature immunity. Genetic predispositions may also contribute, though specific markers remain under investigation.

Recognizing the Two Primary Forms of FIP

FIP manifests in two overlapping forms: effusive (wet) and noneffusive (dry), each with distinct yet sometimes co-occurring signs.

• Wet FIP: Characterized by fluid accumulation in body cavities, this form produces a pot-bellied appearance from abdominal ascites or respiratory distress from pleural effusion. The fluid, a viscous, yellow exudate, stems from vasculitis-induced vascular leakage.
• Dry FIP: Lacking significant effusions, this variant involves granulomatous inflammation in organs like the eyes, brain, kidneys, liver, or lungs. Symptoms include uveitis, neurological deficits such as ataxia or seizures, jaundice, and weight loss.

Early nonspecific signs—fever, anorexia, lethargy—precede progression, with symptoms worsening over weeks to months absent intervention.

Clinical Signs and Progression

Initial FIP symptoms mimic common feline ailments: cyclic fevers unresponsive to antibiotics, appetite loss, and malaise. As disease advances:

• Wet form cats develop dyspnea, muffled heart sounds, or abdominal distension.
• Dry form leads to ocular issues (cloudy eyes, retinal detachment), neurological abnormalities (tremors, behavioral changes), polyuria/polydipsia, vomiting, or icterus.

Without treatment, multi-organ failure ensues, often necessitating euthanasia within weeks. Progression varies; some cats linger months with supportive care.

Diagnostic Challenges in FIP

Confirming FIP proves difficult due to no single definitive test. Veterinarians rely on a multimodal approach:

Risk-based assessment aids: young age, overcrowding, and icterus heighten suspicion. Advanced imaging (ultrasound, MRI) reveals organ lesions.

Breakthrough Treatments: From Fatal to Manageable

Historically, FIP treatment focused on palliation—corticosteroids (prednisolone 2-4 mg/kg daily), immunosuppressants (cyclophosphamide), and supportive measures like fluid drainage, nutritional support, and antibiotics for secondary infections. These extended life modestly but rarely cured.

Revolutionary change arrived with nucleoside analogs targeting viral RNA polymerase. GS-441524, the active metabolite of remdesivir, emerged as frontrunner. Administered orally or via injection for 84 days (or potentially 42-84 days), it yields 80-90% remission rates in trials. Neurological/ocular cases require higher doses (10-15 mg/kg vs. 4-6 mg/kg for wet form). Remdesivir and EIDD-1931 (molnupiravir) offer alternatives.

Treatment monitoring involves serial bloodwork, titers, and imaging. Relapse, though rare (<10%), prompts re-induction. Long-term data, post-2024 FDA considerations, affirm durability.

Supportive Care and Monitoring

Beyond antivirals, comprehensive care optimizes outcomes:

• Fluid therapy for dehydration/hypoalbuminemia.
• Appetite stimulants, antiemetics.
• Drainage of effusions for comfort.
• Blood transfusions for severe anemia.
• Antibiotics (e.g., amoxicillin) prophylactically.

Owners track weight, appetite, and activity; veterinarians assess via qPCR viral loads.

Prevention Strategies for Cat Owners

No vaccine exists reliably due to mutation challenges. Core prevention:

• Minimize household cat density.
• Quarantine new cats 4-6 weeks; test FCoV status.
• Hygiene: daily litter scooping, disinfectants effective against coronaviruses.
• Stress reduction via enrichment, spay/neuter.
• Avoid purebred overbreeding in high-risk lines.

Breeding programs screen for low-shedding FCoV strains.

Prognosis in the Antiviral Era

Pre-2022, prognosis neared 0%; now, with prompt GS-441524, >85% achieve sustained remission. Early diagnosis remains key—delays reduce efficacy. Survivors lead normal lives, though lifelong FCoV shedding monitoring advised.

Frequently Asked Questions (FAQs)

Is FIP contagious to other cats or humans?

FIP itself isn’t directly contagious; FCoV spreads via feces, but only ~10% progress to FIP. Humans/canine unaffected.

Can my cat recover from FIP without treatment?

Extremely rare; spontaneous remission <1%.

How much does FIP treatment cost?

GS-441524 regimens: $2,000-$10,000 USD, varying by weight/duration/region.

Is there a home test for FIP?

No; professional diagnostics essential.

Can vaccinated cats still get FIP?

No approved vaccine; prior attempts failed.

Similar Articles

Breathing Challenges in Flat-Faced Dogs

Diabetes in Dogs Guide

Nighttime Safety for Outdoor Cats

Managing Resource Guarding in Dogs

Cat Kneading Explained

Adding a Second Dog: Key Decisions

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to fluffyaffair,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete